189 related articles for article (PubMed ID: 26246307)
1. Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Diagnosed Between 1991 and 2013.
Rahmattulla C; Berden AE; Wakker SC; Reinders ME; Hagen EC; Wolterbeek R; Bruijn JA; Bajema IM
Arthritis Rheumatol; 2015 Dec; 67(12):3270-8. PubMed ID: 26246307
[TBL] [Abstract][Full Text] [Related]
2. Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis.
van Daalen EE; Rizzo R; Kronbichler A; Wolterbeek R; Bruijn JA; Jayne DR; Bajema IM; Rahmattulla C
Ann Rheum Dis; 2017 Jun; 76(6):1064-1069. PubMed ID: 27899372
[TBL] [Abstract][Full Text] [Related]
3. Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials.
Heijl C; Harper L; Flossmann O; Stücker I; Scott DG; Watts RA; Höglund P; Westman K; Mahr A;
Ann Rheum Dis; 2011 Aug; 70(8):1415-21. PubMed ID: 21616914
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic antibody-associated vasculitis and malignancy.
Wester Trejo MAC; Bajema IM; van Daalen EE
Curr Opin Rheumatol; 2018 Jan; 30(1):44-49. PubMed ID: 28957961
[TBL] [Abstract][Full Text] [Related]
5. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA
Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Malignancy Prior to Antineutrophil Cytoplasmic Antibody-associated Vasculitis Compared to the General Population.
van Daalen EE; Rahmattulla C; Wolterbeek R; Bruijn JA; Bajema IM
J Rheumatol; 2017 Mar; 44(3):314-318. PubMed ID: 28089971
[TBL] [Abstract][Full Text] [Related]
7. Malignancy is increased in patients with antineutrophil cytoplasmic antibody-associated vasculitis in China.
Han XY; Li ZY; Zhao MH; Little MA; Chen M
Arthritis Res Ther; 2024 May; 26(1):113. PubMed ID: 38822382
[TBL] [Abstract][Full Text] [Related]
8. Malignancies in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis: A Population-based Cohort Study.
Heijl C; Westman K; Höglund P; Mohammad AJ
J Rheumatol; 2020 Aug; 47(8):1229-1237. PubMed ID: 31474595
[TBL] [Abstract][Full Text] [Related]
9. Brief Report: Menopause and Primary Ovarian Insufficiency in Women Treated for Antineutrophil Cytoplasmic Antibody-Associated Vasculitides.
Tuin J; Sanders JS; van Beek AP; Hoek A; Stegeman CA
Arthritis Rheumatol; 2016 Apr; 68(4):986-92. PubMed ID: 27023359
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies.
Shang W; Ning Y; Xu X; Li M; Guo S; Han M; Zeng R; Ge S; Xu G
PLoS One; 2015; 10(5):e0126016. PubMed ID: 25973882
[TBL] [Abstract][Full Text] [Related]
11. Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Faurschou M; Westman K; Rasmussen N; de Groot K; Flossmann O; Höglund P; Jayne DR;
Arthritis Rheum; 2012 Oct; 64(10):3472-7. PubMed ID: 22614882
[TBL] [Abstract][Full Text] [Related]
12. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
Mohammad AJ; Segelmark M
J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
[TBL] [Abstract][Full Text] [Related]
13. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.
Faurschou M; Sorensen IJ; Mellemkjaer L; Loft AG; Thomsen BS; Tvede N; Baslund B
J Rheumatol; 2008 Jan; 35(1):100-5. PubMed ID: 17937462
[TBL] [Abstract][Full Text] [Related]
14. Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis.
Faurschou M; Mellemkjaer L; Voss A; Keller KK; Hansen IT; Baslund B
Rheumatology (Oxford); 2015 Aug; 54(8):1345-50. PubMed ID: 25234661
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study.
Yang L; Xie H; Liu Z; Chen Y; Wang J; Zhang H; Ge Y; Hu W
BMC Nephrol; 2018 Jun; 19(1):138. PubMed ID: 29902982
[TBL] [Abstract][Full Text] [Related]
16. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
[TBL] [Abstract][Full Text] [Related]
17. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
18. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
[TBL] [Abstract][Full Text] [Related]
19. Cancer development in Korean patients with ANCA-associated vasculitis: a single centre study.
Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):73-77. PubMed ID: 29465366
[TBL] [Abstract][Full Text] [Related]
20. Risk of opportunistic infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis, using a Japanese health insurance database.
Sakai R; Tanaka E; Nishina H; Suzuki M; Yamanaka H; Harigai M
Int J Rheum Dis; 2019 Nov; 22(11):1978-1984. PubMed ID: 31338986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
